Attention Deficit/Hyperactivity Disorder (ADHD) is one of the most common childhood disorders and can persist through adolescence and into adulthood. It is characterized by difficulty maintaining focus and attention, challenges with impulse control, and hyperactivity (Source: National Institute of Health). More than 6 million (9.4 per cent) of children in the U.S. have an ADHD diagnosis, according to reports.
Several medications are approved for the treatment of ADHD and are classified as either stimulants or non-stimulants. Research indicates that stimulant medications are the most effective and are typically used as first-line treatment for managing ADHD symptoms. However, most currently available extended-release formulations of Stimulants require multiple doses per day and often fail to provide consistent coverage across the entire active day.
For comments and feedback contact: editorial@rttnews.com
May 01, 2026 15:54 ET Central banks dominated the economics news flow this week with almost all major ones announcing their latest policy decisions and many boosted expectations for a rate hike in June. In other news, several countries released the preliminary data for first quarter economic growth. In the U.S., comments by Fed Chair Jerome Powell were also in focus as his term ends this month.